Ono Pharmaceutical Co., Ltd.

OTC
OPHLY
Stock
Yield per half year: -13.49%
Dividend yield: 2.17%
Sector: Healthcare

Ono Pharmaceutical Co., Ltd.

4.984.984.414.413.833.833.263.26Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
0.1011 46.56 -99.78% 12.84 -99.21%
P/S 0.0104 4.29 -99.76%
P/BV 0.0065 5.34 -99.88%
P/FCF 0.0679 27.86 -99.76%
Ev/Ebitda 7.52 17.57 -57.23%
Ev/S 1.41 4.42 -68.01%
Ev/FCF 9.24 40.58 -77.23%
E/P 9.89 1.1 803.14%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
6/10
18.8 23.09 -18.58% 33.02 -43.06%
ROE 6.4 14.32 -55.33%
ROA 4.7 7.27 -35.32%
ROIC 20.64 14.12 46.19%
ROS 10.28 10.85 -5.26%
ROCE 8.2 17.52 -53.19%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
7/10
1.6 2.87 -44.22% 0.3705 +332.43%
Nеt Debt/Ebitda -0.6324 0.0129 -5020.05%
Debt/Ratio 0.1378 0.2142 -35.64%
Debt/Equity 0.35 1.11 -68.4%
Debt/Net Income 2.93 8.89 -67.01%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
5.43/10
2.17 1.61 34.78% 2.34 -7.17%
Number of years of dividend growth 1 1.68 -40.48%
DSI 0.8571 0.7823 9.56%
Average dividend growth 6.17 -397.13 -101.55%
Average percentage for 5 years 2.34 3.27 -28.44%
Average percentage for payments 57.16 150.93 -62.13%
Difference from average difference in sector 0.56

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
7/10
57.42 337.08 -82.97%
Growth impulse Ebitda in 5 years -21.66 382.84 -105.66%
Growth impulse Net Income in 5 years -33.65 233.81 -114.39%
Growth impulse FCF in 5 years 38.72 215.4 -82.02%
Growth impulse EPS in 5 years -18.2 418.39 -104.35%
IP Score
6.09/10

Similar companies

Astellas Pharma Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription